close

Pepti Moves to All-In Monthly Pricing for Physician-Guided Peptide Therapy, With No Membership, Consult or Visit Fees

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

DALLAS, TX / ACCESS Newswire / November 3, 2026 / Pepti LLC, a modern telehealth platform connecting patients with independently licensed U.S. physicians, has announced a new, simplified pricing model designed to make personalized, physician-guided care more transparent and accessible.

Under the new model, every treatment offered through Pepti features one clear monthly price, with no additional membership fees, consultation fees, or hidden charges.

The price displayed on each treatment page includes prescribed medication, physician evaluation, ongoing medical oversight, shipping, and unlimited messaging with the patient's care team.

Monthly treatment options include:

  • Compounded semaglutide: Starting at $99
  • Compounded tirzepatide: Starting at $159
  • Peptide therapies: Approximately $209, depending on treatment

The pricing structure reflects Pepti's commitment to removing unnecessary complexity from the healthcare experience while maintaining access to personalized, physician-guided treatment.

"Healthcare pricing shouldn't be complicated," said a Pepti spokesperson. "We believe patients deserve to know exactly what they're paying before beginning treatment. By bringing everything together under one transparent monthly price, we're making it easier for people to explore personalized care without worrying about unexpected fees."

A Simpler Approach to Personalized Care

Pepti was built around the idea that accessing personalized healthcare should be straightforward, convenient, and supported by licensed medical professionals.

Patients begin with a free online health assessment, providing information about their medical history and health goals. An independently licensed physician then reviews the information and determines whether treatment is medically appropriate.

When prescribed, medications are prepared by licensed U.S. compounding pharmacies and shipped directly to patients' homes.

Through the Pepti mobile app, patients can stay connected to their care team, request prescription refills, access available laboratory results, and manage their treatment plans from one place.

The platform also offers at-home blood testing, allowing patients to access certain laboratory services without a traditional clinic visit.

Transparency Beyond Pricing

In addition to simplifying treatment costs, Pepti emphasizes transparency in pharmacy sourcing and medication quality.

The company provides access to independent laboratory testing reports for dispensed medications through its website, giving patients additional information about the quality-testing processes associated with their treatment.

These reports are available at hellopepti.com/quality/lab-results.

By combining physician-guided care, clear pricing, pharmacy fulfillment, and digital patient support, Pepti aims to create a more connected and accessible telehealth experience.

About Pepti

Pepti LLC is a U.S.-based telehealth platform focused on personalized, physician-guided peptide therapy and related wellness treatments. Through its network of independently licensed physicians and licensed U.S. compounding pharmacies, Pepti connects patients with individualized treatment options and ongoing care through a convenient digital platform.

Learn more at hellopepti.com.

Media Contact
Pepti Press Team
press@hellopepti.com
https://hellopepti.com

Medical Disclaimer: Pepti is a telehealth platform. Medical services are provided by independently licensed physicians. All treatments require appropriate medical evaluation, and a consultation does not guarantee a prescription. Individual results vary. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. They are prepared by licensed compounding pharmacies pursuant to valid prescriptions, subject to applicable law. Information provided is for educational purposes and does not constitute medical advice.

SOURCE: Pepti LLC



View the original press release on ACCESS Newswire

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.69
+5.06 (2.06%)
AAPL  331.90
-6.42 (-1.90%)
AMD  483.90
+17.06 (3.65%)
BAC  49.66
+0.09 (0.18%)
GOOG  278.27
+0.23 (0.08%)
META  621.03
+14.30 (2.36%)
MSFT  520.99
+13.87 (2.74%)
NVDA  206.69
+4.63 (2.29%)
ORCL  126.19
+6.97 (5.85%)
TSLA  398.50
-5.32 (-1.32%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at /week.